Skip to content
soligenix-logo Soligenix Logo
Main Menu
  • About Soligenix
    • Corporate Overview
    • Board of Directors
    • Executive Team
    • Scientific Advisory Boards
      • Scientific Advisory Board Cutaneous T-Cell Lymphoma
      • Scientific Advisory Board Oral Mucositis
      • Scientific Advisory Board Pediatric Crohn’s Disease
      • Scientific Advisory Board Antibiotic Resistance & Emerging Infectious Disease
  • Careers
    • Job Openings
  • Contact
  • Pipeline + Programs
    • Pipeline
    • Specialized BioTherapeutics
      • HyBryte™ for Cutaneous T-Cell Lymphoma (CTCL)
      • SGX942 for Oral Mucositis Treatment
      • SGX203 for Pediatric Crohn’s Disease
      • SGX201 for Radiation Enteritis Treatment
    • Public Health Solutions
      • RiVax® to Prevent Ricin Poisoning
      • SGX943 for Infectious Disease
      • ThermoVax®: Thermostabilized Vaccines for Global Use
    • Reference Literature
      • Specialized BioTherapeutics
      • Public Health Solutions
    • Relevant Publications
  • Clinical Trials
  • Our Focus
    • Specialized BioTherapeutics
      • Cutaneous T-Cell Lymphoma
      • Oral Mucositis
      • Pediatric Crohn’s Disease
      • Radiation Enteritis
    • Public Health Solutions
      • What is Ricin Intoxication?
      • Thermal Stabilization of Vaccines
      • Antibiotic Resistant & Emerging Infectious Disease
  • Partnering
  • Investors
T-cell masthead image

Pre-Print

Pre-Print

Endpoint and Epitope-specific Antibody Responses as Correlates of Vaccine-mediated Protection of Mice against Ricin Toxin

  • External Link
Greta Van Slyke, Dylan J Ehrbar, Jennifer Doering, Jennifer L. Yates, Ellen S.Vitetta, Oreola Donini, Nicholas J Mantis. Endpoint and Epitope-specific Antibody Responses as Correlates of Vaccine-mediated Protection of Mice against Ricin Toxin. BioRxiv. 2020.
Read More
© Soligenix, 2021. All Rights Reserved.
  • Legal Notices
  • Site Map
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
  • Instagram